Kinnate Biopharma Inc
(KNTE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,708 | -53,971 | -26,902 | -89,763 | -63,604 |
| Depreciation Amortization | 1,386 | 1,081 | 532 | 2,000 | 1,447 |
| Other Working Capital | 3,396 | -1,397 | 506 | 1,624 | 2,843 |
| Other Operating Activity | 14,640 | 9,659 | 4,777 | 15,074 | 10,772 |
| Operating Cash Flow | $-65,286 | $-44,628 | $-21,087 | $-71,065 | $-48,542 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -131,082 | -92,518 | -73,577 | -247,142 | -216,613 |
| PPE Investments | -2,629 | -2,566 | -2,016 | -769 | -68 |
| Sale Of Investment | 109,314 | 53,731 | 10,963 | 67,337 | 33,769 |
| Investing Cash Flow | $-24,397 | $-41,353 | $-64,630 | $-180,574 | $-182,912 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 967 | 777 | 125 | 1,619 | 827 |
| Other Financing Activity | 0 | 0 | 0 | 34,618 | 34,853 |
| Financing Cash Flow | $967 | $777 | $125 | $36,237 | $35,680 |
| Exchange Rate Effect | -2 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 150,060 | 150,060 | 150,060 | 365,462 | 365,462 |
| End Cash Position | 61,342 | 64,856 | 64,468 | 150,060 | 169,688 |
| Net Cash Flow | $-88,718 | $-85,204 | $-85,592 | $-215,402 | $-195,774 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,286 | -44,628 | -21,087 | -71,065 | -48,542 |
| Capital Expenditure | -2,629 | -2,566 | -2,016 | -769 | -68 |
| Free Cash Flow | -67,915 | -47,194 | -23,103 | -71,834 | -48,610 |